We’re not heading into a world with no work. We’re heading into a world with too much work and not enough people to do it.
Regenerative Orthopedics & Sports Medicine (ROSM) is proud to announce its selection as a premier clinical site for a pioneering new study aimed at transforming the treatment landscape for ...
The gross proceeds to IMUNON from the offering are expected to be approximately $7.0 million, before deducting placement agents’ fees and other estimated offering expenses. The offering is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback